[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608980":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":31,"responsibleParty":48,"collaborators":50,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":20,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":20,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":79,"whyStopped":20,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"TECLens, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Group","EXPERIMENTAL","Open label treatment arm",[13],"Device: Quantitative refractive crosslinking",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Quantitative refractive crosslinking","Non-invasive corneal cross-linking device delivering controlled UV light through a contact lens platform for biomechanical stabilization of the cornea.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Patrick Lopath","CONTACT","919-824-5224","plopath@teclens.com",{"name":28,"role":24,"phone":29,"phoneExt":20,"email":30},"Ibrahim Seven","440-485-9091","ibrahim.seven@teclens.com",[32],{"facility":33,"status":20,"city":34,"state":35,"zip":20,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Asian Eye Institute","Makati City","Philippines","PH",{"type":38,"coordinates":39},"Point",[40,41],121.03269,14.55027,{"lat":41,"lon":40},[44],{"name":45,"role":24,"phone":46,"phoneExt":20,"email":47},"Mary Ann Catacutan","632-8898-2019","mtcatacutan@asianeyeinstitute.com",{"type":49,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[51,54],{"name":52,"class":53},"Robert Ang, MD","UNKNOWN",{"name":55,"class":53},"Robert Ang, MD - Asian Eye Institute","100608980","open-label-multi-center-phase-i-study-of-teclens-quantitative-refractive-crosslinking-in-presbyopia-aged-patients-100608980",false,"NCT07208604","Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients.","Open Label, Multi-center, Phase I Study of TECLens Corneal Crosslinking System for Correction of Refractive Error in Patients of Presbyopia Age.","Inclusion Criteria:\n\n* Adults aged 40-65 years\n* Healthy cornea\n* Refractive error between +4.0 D and -5.0 D\n* Phakic or monofocal pseudophakic (≥6 months post IOL placement)\n* Visual acuity correctable by ±0.25 D\n\nExclusion Criteria:\n\n* Corneal dystrophy, scarring, or prior corneal crosslinking\n* Astigmatism \\>1.0 D\n* Active ocular infection, inflammation, or uncontrolled dry eye\n* Advanced glaucoma or diabetic retinopathy\n* History of delayed corneal healing\n* Pregnancy, breastfeeding, or planning pregnancy during study period\n* Certain medications (e.g., isotretinoin)\n* Recent participation in other investigational drug\u002Fdevice studies (within 30 days)\n* Patients with uncontrolled dry eye or surface disease","ALL","40 Years","65 Years",{"count":67,"type":68},25,"ESTIMATED","INTERVENTIONAL",[71],"NA","An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.",[74],"Presbyopia",[76,74,77,78],"Corneal crosslinking","Myopia","Hyperopia","NOT_YET_RECRUITING","2025-09-28",{"date":82,"type":83},"2025-10-06","ACTUAL",{"date":85,"type":68},"2025-09-30",{"date":87,"type":68},"2026-08",{"name":5,"class":6},1]